Unipolar Depression vs Bipolar Depression: A Clinician Guide

For unipolar depression vs bipolar depression, this table is a starting point for a longitudinal assessment, not a diagnosis from one symptom or one screening score.

Worked differential

Why the distinction matters

When you assess unipolar depression vs bipolar depression, begin with the client’s baseline and the sequence of change rather than the current symptom count. Unipolar depression and bipolar depression can share low mood, anhedonia, fatigue, sleep change, appetite change, impaired concentration, psychomotor change, and thoughts of death. A cross-sectional symptom list cannot answer whether the client has had a distinct period of mania or hypomania. The diagnostic history is longitudinal: ask what changed from baseline, how long it lasted, what other people noticed, and what happened afterward.

Use current diagnostic language in the record. “Unipolar depression” is a useful contrast term for depressive disorders without a known history of mania or hypomania; it is not a substitute for a complete diagnostic assessment. Do not assign a bipolar diagnosis from one symptom, one screening score, or a single medication response. Paraphrase diagnostic criteria rather than copying them into the note.

Keep this differential separate from a mood chart or an ICD-10 lookup. The bipolar mood chart template can organize observations over time, and the mood-disorder ICD-10 guide can support code lookup after the formulation is established. For overlapping anxiety symptoms, see the anxiety and bipolar guide; for medication changes, review the new bipolar medication article.

Ask about past hypomania or mania directly

A client may not call a past episode “hypomania” or “mania.” Use plain, behavior-based questions and compare the period with the client’s usual functioning:

• “Have you had several days when you needed much less sleep but did not feel tired?”
• “During that time, were you more talkative, driven, social, or productive than usual?”
• “Did your thoughts move faster, or did you take on more plans than you could complete?”
• “Did anyone comment that you seemed unusually energized, irritable, confident, or unlike yourself?”
• “Were there changes in spending, sex, driving, work, conflict, substances, or other risk-taking?”
• “How long did the change last, and what happened when it ended?”
• “Did it cause major impairment, require hospitalization, or include psychosis?”
• “What medications, substances, sleep disruption, medical illness, or life events were present?”

Ask about the whole episode rather than treating one behavior as proof. Reduced sleep with exhaustion is different from reduced need for sleep with sustained energy. Confidence is not automatically grandiosity, and irritability is not automatically mania. Record the client’s words, the observed change, collateral when available, duration, impairment, and your remaining uncertainty.

Review the features that can mislead the differential

Atypical features, seasonal changes, postpartum timing, psychotic symptoms, mixed features, recurrent episodes, early onset, and rapid shifts can all change the questions you ask. None is a stand-alone bipolar diagnosis. Review medical conditions, sleep disorders, prescribed medications, substances, withdrawal, trauma-related activation, and other psychiatric explanations when they could account for the presentation.

Antidepressant response also needs context. A nonresponse may reflect an inadequate trial, adherence barriers, comorbidity, wrong target, or a different diagnosis. Activation after an antidepressant may be clinically important, but it does not by itself prove bipolar disorder. Document timing, sleep need, energy, speech, activity, impulsivity, dose and adherence when known, and whether the change resolved after the medication or another factor changed. Coordinate medication questions with the prescribing clinician; do not start, stop, or change a medication from this guide.

Build the note around evidence and uncertainty

A useful differential note lets another clinician see why you are considering each possibility. Separate what the client reports, what you observe, what collateral supports, and what still needs assessment.

Use screening tools as prompts, not verdicts

The Mood Disorder Questionnaire (MDQ) and Hypomania Checklist-32 (HCL-32) can help identify experiences to explore. They are not substitutes for a diagnostic interview, collateral, longitudinal records, or assessment of impairment and exclusions. The MDQ was developed as a screening instrument for bipolar spectrum disorder (Hirschfeld et al., 2000). The HCL-32 was developed to detect hypomanic features in people with depression (Angst et al., 2005). Follow the instrument’s licensing and administration instructions rather than reproducing its items in a handout.

If a screen is positive, document the score and date, the client’s understanding of the items, the episodes that require clarification, impairment, collateral, and your plan. If a screen is negative but the history remains concerning, document why further assessment is still indicated. A screen should open a conversation, not close the differential.

What to hand off and what to monitor

Coordinate with the prescriber when the client reports activation, reduced need for sleep, mixed symptoms, psychosis, significant medication effects, adherence concerns, or a meaningful change in risk. With consent, share a concise timeline rather than a broad label: onset, sleep need, energy, activity, speech, behavior, medication dates, substances, safety findings, and the client’s goals.

At follow-up, compare the client with their own baseline. Track mood, sleep quantity and need, energy, activity, impulsivity, medication changes, substance use, functioning, and safety. A mood measure can support monitoring, but a score does not replace clinical judgment. Use urgent or emergency procedures for imminent safety concerns, severe impairment, psychosis, or inability to care for basic needs according to your setting’s protocol. If a client arrives asking about unipolar depression vs bipolar depression after reading online, return to the episode history and document the evidence rather than assigning a label from a symptom list.

Help clients bring a consistent record to follow-up with this printable mood chart for sleep, energy, mood changes, and questions for the care team.

How Emosapien supports the documentation thread

Emosapien can help you keep the longitudinal record visible while you review a draft: the Scribe Agent can organize current depressive symptoms, past activation, safety findings, treatment history, collateral, and unresolved questions. It does not diagnose bipolar disorder, decide whether a medication should change, or replace your clinical judgment. You review, correct, and sign the note.

Use the review as a pause between gathering information and committing to a formulation. First check that the current symptoms are supported by the client’s words, observed behavior, and the time period documented. Then check the history for a distinct change from baseline, not only a familiar label or a single positive screen. Look for the duration of any elevated or activated period, the need for sleep, changes in speech and activity, impairment, collateral, substances, medical contributors, and medication timing. If the evidence is incomplete, preserve that uncertainty in the draft and identify the next question, record, or collateral contact that could clarify it. A useful note also makes the safety plan visible, names who will coordinate medication questions, and states when the client will be seen again. These checks support continuity when another clinician reviews the record or when the client’s presentation changes. They keep documentation anchored to evidence while leaving diagnosis and treatment decisions with the qualified care team.

When the record contains conflicting accounts, note the source and date rather than smoothing the differences away. A client may remember an activated period differently from a partner, or a medication list may not match what the client is taking. Capture both accounts, identify what needs confirmation, and avoid converting uncertainty into a definitive label. This makes the draft easier to update after collateral, records, or a prescriber conversation. It also gives the client a clear explanation of what you are still assessing and why the next follow-up matters.

References

• Angst, J., Adolfsson, R., Benazzi, F., Gamma, A., Hantouche, E., Meyer, T. D., Skeppar, P., Vieta, E., & Scott, J. (2005). The HCL-32: Toward a self-assessment tool for hypomanic symptoms in outpatients. Journal of Affective Disorders, 88(2), 217–233. DOI.
• Hirschfeld, R. M. A., Williams, J. B. W., Spitzer, R. L., et al. (2000). Development and validation of a screening instrument for bipolar spectrum disorder: The Mood Disorder Questionnaire. American Journal of Psychiatry, 157(11), 1873–1875. DOI.
• National Institute of Mental Health. (n.d.). Bipolar disorder.